Lipid formulations of amphotericin B for empirical treatment of fever and neutropenia.
Frothingham
Richard
R
D000666:Amphotericin B / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000737:chemistry / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D002986:Clinical Trials as Topic; D005334:Fever / Q000188:drug therapy*; D006801:Humans; D008055:Lipids / Q000737:chemistry*; D009503:Neutropenia / Q000188:drug therapy*
D000935:Antifungal Agents; D008055:Lipids; D000666:Amphotericin B